Vuzix® Corporation (NASDAQ:VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company has signed an agreement with L3Harris Technologies (“L3Harris”) to develop a customized waveguide-based optics engine that is intended to be used in headborne systems designed for military applications.
Lexicon To Present Study Results Relating To Sotagliflozin And LX9211 At The 59th Annual Meeting Of The European Association For The Study Of Diabetes
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failureLX9211 is an investigational, non-opioid treatment for diabetic peripheral neuropathic painTHE WOODLANDS, Texas, Sept. 26, 2023 (GLOBE
